Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
Your fast track to the ultramodern lab
Your fast track to the ultramodern lab
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
World-leading cancer diagnostics for everyone
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
World-leading cancer diagnostics for everyone
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI-supported workflow to optimize quality and response times, initially within prostate.
How can an ultramodern laboratory, 100% specialized in uropathology, benefit you and your patients?
Welcome to our booth at Urologidagarna in Malmö, October 5–7. Let’s talk about how you can get visual and intuitive pathology reports within 5 days with high and consistent quality, created by world-leading AI in collaboration with experienced uropathologists.
Your patient, our priority
Urologidagarna i Malmö, booth #43
Malmö Live
October 5–7, 2022
Malmö Live
October 5–7, 2022
Learn more about Inify Laboratories
Watch the video presentation
CUSTOMER CASE | Capio Urosurgical Center
“We had issues with long lead times for receiving results to our prostate biopsies. Inify delivers a solution where we get results within 5 working days. That was the main reason we started sending our samples to them”.
Martin Bergman
Consultant Urologist, CEO and founder
Capio Urosurgical Center
Capio Urosurgical Center
One out of seven will be diagnosed with prostate cancer
Handling of prostate biopsies makes up an increasing amount of workload for today’s pathology labs. Here, powerful decision support tools – such as Inify Prostate – have the potential to save valuable time for the pathologist, while ensuring a more objective, consistent and accurate evaluation of the biopsies.
PANEL TALK
Over 1,000 patients diagnosed: Panel talk Q2 report 2024
Inify reports sales of SEK 3.6 million in the quarter – up 62% compared to Q1. By the end of June, the laboratory had been open for over a year and had diagnosed more than 1,000 patients. More details about the laboratory operations and its success factors are discussed in a panel talk led by Ole Eikeland with Inify’s CEO Fredrik Palm and Laboratory Director Emelie Edvigsson.
PANEL TALK
Establishment in the UK and expansion in diagnostics: Panel talk Q3 report 2024
Inify has decided to establish its operations in the United Kingdom and to expand diagnostics into the gastrointestinal field. "The national health care system NHS in the UK has a high focus on pathways for patients that are going through cancer investigations, and here is exactly where we provide unique value" says Inify´s CEO Fredrik Palm. Listen to the panel talk led by Ole Eikeland with CEO Fredrik Palm for more details.
Coming soon
Friday, October 25th at 13:00
Panel talk about Inify’s third quarter 2024
Coming soon
Friday, October 25th at 13:00
Panel talk about Inify’s third quarter 2024
-
Investor News
News
Finansavisen highlights Inify Laboratories
2023-07-03